Novabiotics announces publication of NP339's Broad Antifungal Activity

Released: Tuesday 1st June 2021

NovaBiotics Announces Publication of Data Elucidating NP339’s Broad Antifungal Activity in Antimicrobial Agents and Chemotherapy

Peer reviewed journal article highlights Company’s novel antifungal peptide’s activity against a broad range of fungal pathogens with no off target cytotoxicity. Full press release here.

View all News